Where The Buying Ran Strongest: 29 Small Cap Stocks At 52-Week Highs
A small group of stocks is showing notable strength, but the business stories behind the prices vary widely.
One stock on today’s 52-week-high list, Apogee Therapeutics (APGE), has gained 57.2% over the last month, a period when the S&P 500 returned +2.4%. It is one of 29 Small Cap stocks from the Russell 3000 at its strongest price of the past year as of Friday, July 10.
The list shows small clusters of strength by industry, including Biotechnology (3 names), Asset Management & Custody Banks (2 names), and Industrial REITs (2 names). This raises a central question for any investor looking at new highs: what kind of business strength is the market pricing in? Below are the names that made the screen.
Friday’s Full 52-Week-High List
The table below shows the 10 largest of the 29 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| AMG | $9.8 Bil | 0.4% | 6.3% | 7.1% | 79.8% |
| NUVL | $9.7 Bil | 0.1% | 0.1% | 0.5% | 52.0% |
| APGE | $9.3 Bil | 0.1% | 0.6% | 57.2% | 261.0% |
| VOYA | $9.1 Bil | 1.1% | 3.4% | 10.3% | 37.2% |
| FR | $8.6 Bil | 0.2% | 4.2% | 4.1% | 39.2% |
| EAT | $8.0 Bil | 2.6% | 4.2% | 22.8% | 9.5% |
| ETSY | $7.8 Bil | 4.3% | 5.3% | 17.9% | 49.7% |
| TRNO | $7.3 Bil | 1.3% | 3.1% | 4.5% | 28.2% |
| MSM | $6.9 Bil | 2.0% | 0.9% | 6.1% | 40.8% |
| CROX | $6.7 Bil | 4.4% | 6.0% | 3.9% | 26.8% |
Is every new high built the same way?
Look at two examples. Affiliated Managers (AMG), the largest company on the list with a market value of about $9.8 billion, trades at 13.0 times trailing earnings. Its revenue grew 4.2% over the last twelve months, and it runs on a 23.0% operating margin.
Then there is First Industrial Realty Trust (FR), from the REITs cluster. It trades at a higher 25.2 times trailing earnings, but its revenue grew 8.8% over the last twelve months. Its operating margin is 41.2%. The numbers show two very different profiles of growth and profitability earning a new high.
So what is the disciplined next step?
A 52-week-high list is a useful tool for finding stocks with positive price action, and strength often persists. But a high is a price, not a final verdict on a company’s value.
The disciplined move is to treat the list as the beginning of the work, not the end. The essential task is to look past the price and determine whether the business fundamentals, its growth, its earnings, its margins, truly earn the new valuation.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
Chasing Highs Is A Reflex. Owning Strength Is A System
A 52-week-high list is seductive: everything on it has been going right. But buying a stock because it is at its high is buying a price, and prices revert; what persists is the quality underneath the run.
The Trefis High Quality (HQ) Portfolio is built to own that quality before and after it makes headlines: roughly 30 businesses selected for consistent cash generation, strong margins, and resilient balance sheets, sized and rebalanced with rules. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Admire the list; own the system.